Assenagon Asset Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-86,011
Closed -$1.62M 1439
2024
Q3
$1.62M Sell
86,011
-19,447
-18% -$373K ﹤0.01% 1020
2024
Q2
$1.99M Sell
105,458
-468,553
-82% -$7.99M ﹤0.01% 904
2024
Q1
$9.32M Buy
574,011
+469,817
+451% +$6.88M 0.02% 448
2023
Q4
$1.32M Sell
104,194
-309,861
-75% -$3.91M ﹤0.01% 1034
2023
Q3
$5.64M Buy
+414,055
New +$6.39M 0.02% 551
2023
Q1
Sell
-66,380
Closed -$888K 1500
2022
Q4
$888K Buy
+66,380
New +$858K ﹤0.01% 1069
2022
Q1
Sell
-887,266
Closed -$14.1M 1546
2021
Q4
$14.1M Buy
+887,266
New +$15.1M 0.04% 256
2021
Q3
Sell
-1,352,501
Closed -$30.8M 1416
2021
Q2
$30.8M Buy
1,352,501
+853,823
+171% +$17.7M 0.1% 174
2021
Q1
$9.16M Buy
498,678
+267,264
+115% +$4.38M 0.04% 362
2020
Q4
$3.45M Buy
231,414
+1,456
+0.6% +$19K 0.02% 422
2020
Q3
$2.58M Buy
229,958
+111,193
+94% +$1.09M 0.01% 528
2020
Q2
$943K Buy
+118,765
New +$984K 0.01% 814
2019
Q3
Sell
-197,664
Closed -$1.69M 1049
2019
Q2
$1.69M Buy
+197,664
New +$1.56M 0.01% 577
2019
Q1
Sell
-75,996
Closed -$629K 1093
2018
Q4
$629K Buy
+75,996
New +$727K 0.01% 769

Other funds holding SEM

Assenagon Asset Management's SEM Position: Q4 2024 in Review

Assenagon Asset Management sold out of Select Medical (SEM) in Q4 2024, closing a stake of 86,011 shares — an estimated $1.62M sold.

Assenagon Asset Management first reported a position in SEM in Q4 2018 and held it in 14 quarters. The position peaked at $30.8M in Q2 2021. 271 funds tracked by Wall St. Rank hold SEM as of Q4 2024.

  • Assenagon Asset Management reported no remaining Select Medical position as of Q4 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 86,011 Select Medical shares in Q4 2024, an estimated $1.62M.
  • Assenagon Asset Management first reported a position in Select Medical in Q4 2018 and held it in 14 quarters.
  • Assenagon Asset Management's Select Medical position peaked at $30.8M in Q2 2021.
  • 271 funds tracked by Wall St. Rank held Select Medical as of Q4 2024.

Based on Assenagon Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.